Paltac Corporation (TYO:8283)
6,630.00
+285.00 (4.49%)
May 14, 2026, 3:30 PM JST
Paltac Revenue
Paltac had revenue of 325.50B JPY in the quarter ending December 31, 2025, with 4.79% growth. This brings the company's revenue in the last twelve months to 1.23T, up 4.04% year-over-year. In the fiscal year ending March 31, 2025, Paltac had annual revenue of 1.19T with 3.14% growth.
Revenue (ttm)
1.23T
Revenue Growth
+4.04%
P/S Ratio
0.31
Revenue / Employee
157.66M
Employees
1,989
Market Cap
385.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.19T | 36.13B | 3.14% |
| Mar 31, 2024 | 1.15T | - | - |
| Mar 31, 2018 | - | - | - |
| Mar 31, 2016 | - | - | - |
| Mar 31, 2014 | - | - | - |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shiseido Company | 973.71B |
| Lion Corporation | 427.06B |
| Rohto Pharmaceutical | 335.80B |
| KOSE Holdings | 330.19B |
| Earth | 179.18B |
| Pola Orbis Holdings | 169.80B |
| Kobayashi Pharmaceutical | 166.80B |
| MTG Co., Ltd. | 118.64B |